International management platform for children's interstitial lung disease (chILD-EU)
M Griese, E Seidl, M Hengst, S Reu, H Rock… - Thorax, 2018 - thorax.bmj.com
Background Children's interstitial lung diseases (chILD) cover many rare entities, frequently
not diagnosed or studied in detail. There is a great need for specialised advice and for …
not diagnosed or studied in detail. There is a great need for specialised advice and for …
[HTML][HTML] GATA2 deficiency in children and adults with severe pulmonary alveolar proteinosis and hematologic disorders
M Griese, R Zarbock, U Costabel, J Hildebrandt… - BMC pulmonary …, 2015 - Springer
Background The majority of cases with severe pulmonary alveolar proteinosis (PAP) are
caused by auto-antibodies against GM-CSF. A multitude of genetic and exogenous causes …
caused by auto-antibodies against GM-CSF. A multitude of genetic and exogenous causes …
[HTML][HTML] Categorizing diffuse parenchymal lung disease in children
M Griese, A Irnstetter, M Hengst, H Burmester… - Orphanet Journal of …, 2015 - Springer
Background Aim of this study was to verify a systematic and practical categorization system
that allows dynamic classification of pediatric DPLD irrespective of completeness of patient …
that allows dynamic classification of pediatric DPLD irrespective of completeness of patient …
[HTML][HTML] Surfactant proteins in pediatric interstitial lung disease
M Griese, E Lorenz, M Hengst, A Schams… - Pediatric …, 2016 - nature.com
Background: Children's interstitial lung diseases (chILD) comprise a broad spectrum of
diseases. Besides the genetically defined surfactant dysfunction disorders, most entities …
diseases. Besides the genetically defined surfactant dysfunction disorders, most entities …
One-year outcomes in a multicentre cohort study of incident rare diffuse parenchymal lung disease in children (ChILD)
S Cunningham, C Graham, M MacLean, P Aurora… - Thorax, 2020 - thorax.bmj.com
We performed a prospective, observational, cohort study of children newly diagnosed with
children's interstitial lung disease (ChILD), with structured follow-up at 4, 8, 12 weeks and 6 …
children's interstitial lung disease (ChILD), with structured follow-up at 4, 8, 12 weeks and 6 …